CLINICAL_TRIALS
trial_result
· 2017-04-13
Clinical Trial Update: Study Evaluating Inotuzumab Ozogamicin In Acute Lymphocytic Leukemia [Phase 2]
Summary
A Pfizer-sponsored Phase 2 trial evaluating inotuzumab ozogamicin in acute lymphoblastic leukemia has completed and posted results in April 2017.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Acute Lymphocytic Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2017-04-13